Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl

Details for Australian Patent Application No. 2004218115 (hide)

Owner Astellas Pharma Inc. Kotobuki Pharmaceutical Co., Ltd.

Inventors Tomiyama, Hiroshi; Oku, Makoto; Asai, Norio; Tokuzaki, Kazuo; Sonegawa, Motoharu; Iwai, Yoshinori; Kikuchi, Kazumi; Nagakura, Yukinori; Watanabe, Toshihiro; Fujiyasu, Jiro

Agent Davies Collison Cave

Pub. Number AU-A-2004218115

PCT Pub. Number WO2004/078715

Priority 2003-061758 07.03.03 JP

Filing date 5 March 2004

Wipo publication date 16 September 2004

International Classifications

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

A61K 031/46 - 8-Azabicyclo [3.2.1] octane

C07D 453/02 Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 211/16 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/60 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/56 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 031/4523 - containing further heterocyclic ring systems

A61K 031/4545

C07D 211/76 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/22 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 031/4465 - only substituted in position 4

C07D 211/18 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 031/4462 - only substituted in position 3

A61K 031/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

C07D 211/26 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/46 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/12 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/16 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 031/4458 - only substituted in position 2, e.g. methylphenidate

A61K 031/497

C07D 211/38 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 031/443

C07D 223/04 Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

A61K 031/451 - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

C07D 211/34 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 031/4409 - only substituted in position 4, e.g. isoniazid, iproniazid

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 215/06 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 031/506 - not condensed and containing further heterocyclic rings

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

C07D 211/30 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 031/5377

C07D 451/02 Heterocyclic compounds containing condensed hetero ring systems

C07D 405/06 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 211/42 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61P 025/04 Drugs for disorders of the nervous system

C07D 211/62 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/078715 Priority application(s): WO2004/078715

29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218127-Method of labeling phosphorylated peptide, method of selective adsorption therefor, complex compound for use therein, process for producing the complex compound and starting compound of the complex compound

2004218098-Method for preparing synthesis gas, method for preparing dimethyl ether using synthesis gas and furnace for preparing synthetic gas